Építés alatt – nem éles oldal
Belépés
Not yet taking people in Franciaország1. fázis

RUPISTAR: A Study in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutation

Key facts

Where
Lyon és Saint-Herblain Cedex, FranciaországSee the 2 sites
Phase
1. fázis

Where in Franciaország

  • Centre Leon BerardLyon, FranciaországToborzás még nem indult
  • Institut De Cancerologie De L OuestSaint-Herblain Cedex, FranciaországToborzás még nem indult

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Evexta Bio
Trial code
EU 2026-527387-33-00
Record updated
2026. november 9.
Építés alatt, nem éles – RUPISTAR: A Study in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutation (2026-527387-33-00) – Frontlight Research